Caron Winslow

Caron Winslow currently serves as Director of Strategic Alliances at Standard BioTools, following the company's merger with SomaLogic in January 2024. Prior to this role, Caron held various leadership positions at SomaLogic, including Director of Strategic Alliances and Partnerships and Director of Global Strategic Accounts for Pharmaceuticals and Academic Alliances. Caron’s experience also includes significant roles at Promega Corporation, Monster Worldwide, Inc, Merck & Co., Inc, and Brandeis University. Caron began an academic journey with a Bachelor of Science in Biochemistry from the University of New Hampshire, followed by graduate coursework at Brandeis University and Harvard University, culminating in a certificate from MIT Sloan School of Management focused on Artificial Intelligence and Business Strategy.